SCHEMBL9872674

SCHEMBL9872674

O=C(c1ccccc1)c1cnc2cccnc2c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KMT2A Q03164 2/20 0.44
FEN1 P39748 1/20 0.43
HTT P42858 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EGLN1 Q9GZT9 4/20 0.42
COMT P21964 1/20 0.42
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
DHODH Q02127 1/20 0.40
AKR1C3 P42330 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3249138 0.84 ALDH1A1 (0.58) ALDH1A1NPSR1MAPTSMN1; SMN2EGLN1
SCHEMBL9873674 0.84 KMT2A (0.42) ALDH1A1KMT2AHTTNPSR1MAPT
Hydrochloric Acid SCHEMBL11567115 0.83 ALDH1A1 (0.57) ALDH1A1NPSR1MAPTSMN1; SMN2EGLN1
SCHEMBL10877533 0.80 ALDH1A1 (0.45) ALDH1A1KMT2ANPSR1EGLN1NPC1
SCHEMBL10877535 0.80 PARP1 (0.51) ALDH1A1EGLN1HPGD
SCHEMBL12564546 0.80 ALDH1A1 (0.45) ALDH1A1KMT2AMAPTEGLN1MEN1
SCHEMBL11729968 0.80 ALDH1A1 (0.45) ALDH1A1KMT2AHTTMAPTSMN1; SMN2
Hydrochloric Acid SCHEMBL11567111 0.78 ALDH1A1 (0.44) ALDH1A1KMT2AHTTMAPTSMN1; SMN2
SCHEMBL6487277 0.77 ALDH1A1 (0.71) ALDH1A1FEN1EGLN1LMNAALOX12
SCHEMBL31023212 0.77 ALDH1A1 (0.71) ALDH1A1FEN1EGLN1LMNAALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5026711-A Prevention and treatment of cardiovascular disorders and infections states; anxiolytic and anti-allergic agents SANOFI (FR) 1991-06-25 US disclosed